Publications by authors named "Ken Aoshima"

Claim this Profile
B
Biomarkers.
Ken Aoshima, Kotaro Sasaki, Noriyuki Kimura, Teruaki Masuda

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Daily Mode of Transportation and Cognitive Function Among Older Adults With Mild Cognitive Impairment: A Cross-Sectional Observational Study.
Teruaki Masuda, Emiko Segawa, Noriyuki Kimura, Takuma Sato, Kenichi Anabuki, Ken Aoshima

Cureus· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between olfactory and gustatory functions: The Iwaki health promotion project 2019.
Kazutaka Yamauchi, Daisuke Matsushita, Nami Shimizume, Reiko Kudo, Yusuke Kohama, Ken Aoshima

Auris Nasus Larynx· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort.
Takaki Oka, Yuki Matsuzawa, Momoka Tsuneyoshi, Yoshitaka Nakamura, Ken Aoshima

Sci Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting positron emission tomography brain amyloid positivity using interpretable machine learning models with wearable sensor data and lifestyle factors.
Noriyuki Kimura, Tomoki Aota, Yasuhiro Aso, Kenichi Yabuuchi, Kotaro Sasaki, Ken Aoshima

Alzheimers Res Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide Database Analysis of Risk Factors Associated with Decreased Activities of Daily Living in Patients with Alzheimer's Disease.
Keishi Akada, Noriyuki Koyama, Yuji Miura, Kentaro Takahashi, Ken Aoshima

J Alzheimers Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide database analysis of insomnia, depression, and sleeping pill prescriptions in hepatocellular carcinoma patients.
Keishi Akada, Noriyuki Koyama, Yuji Miura, Ken Aoshima

Curr Med Res Opin· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A deep learning algorithm for sleep stage scoring in mice based on a multimodal network with fine-tuning technique.
Keishi Akada, Takuya Yagi, Yuji Miura, Carsten T Beuckmann, Noriyuki Koyama, Ken Aoshima

Neurosci Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world database analysis of the characteristics and treatment patterns of patients with endometrial cancer in Japan.
Keishi Akada, Noriyuki Koyama, Takuma Miura, Eiji Fukunaga, Yuji Miura, Ken Aoshima

Curr Med Res Opin· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Database analysis of patients with hepatocellular carcinoma and treatment flow in early and advanced stages.
Keishi Akada, Noriyuki Koyama, Shigeru Taniguchi, Yuji Miura, Ken Aoshima

Pharmacol Res Perspect· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study.
Takuya Yagi, Michio Kanekiyo, Junichi Ito, Ryoko Ihara, Kazushi Suzuki, Ken Aoshima

Alzheimers Dement (N Y)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Peak Detection for Low Resolution MALDI-TOF Mass Spectrometry.
Jingwen Yao, Shin-Ichi Utsunomiya, Shigeki Kajihara, Tsuyoshi Tabata, Ken Aoshima

Mass Spectrom (Tokyo)· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GlycanAnalysis Plug-in: a database search tool for N-glycan structures using mass spectrometry.
Kentaro Morimoto, Takashi Nishikaze, Akiyasu C Yoshizawa, Shigeki Kajihara, Ken Aoshima

Bioinformatics· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease.
Yoshiaki Sato, Francois Bernier, Yasukazu Yamanaka, Ken Aoshima, Yoshiya Oda

Alzheimers Dement (Amst)· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple peak detection and label-free quantitation algorithm for chromatography-mass spectrometry.
Ken Aoshima, Kentaro Takahashi, Masayuki Ikawa, Takayuki Kimura, Mitsuru Fukuda

BMC Bioinformatics· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models.
Yasuhiro Funahashi, Kiyoshi Okamoto, Yusuke Adachi, Taro Semba, Mai Uesugi, Ken Aoshima

Cancer Sci· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass++: A Visualization and Analysis Tool for Mass Spectrometry.
Satoshi Tanaka, Yuichiro Fujita, Howell E Parry, Akiyasu C Yoshizawa, Kentaro Morimoto, Ken Aoshima

J Proteome Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miRNA biomarkers for Alzheimer's disease.
Pavan Kumar, Zoltan Dezso, Crystal MacKenzie, Judy Oestreicher, Sergei Agoulnik, Ken Aoshima

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of relaxin-3-induced downstream pathway resulting in anxiolytic-like behaviors in rats based on a microarray and peptidome analysis.
Chihiro Miyamoto Nakazawa, Kohdoh Shikata, Mai Uesugi, Hiroyuki Katayama, Ken Aoshima

J Recept Signal Transduct Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology.
Yoshiaki Sato, Ikumi Suzuki, Tatsuji Nakamura, Francois Bernier, Ken Aoshima

J Lipid Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative and wide-ranging profiling of phospholipids in human plasma by two-dimensional liquid chromatography/mass spectrometry.
Yoshiaki Sato, Tatsuji Nakamura, Ken Aoshima, Yoshiya Oda

Anal Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MassBank: a public repository for sharing mass spectral data for life sciences.
Hisayuki Horai, Masanori Arita, Shigehiko Kanaya, Yoshito Nihei, Tasuku Ikeda, Ken Aoshima

J Mass Spectrom· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polar anionic metabolome analysis by nano-LC/MS with a metal chelating agent.
Khin Than Myint, Taisuke Uehara, Ken Aoshima, Yoshiya Oda

Anal Chem· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards.
Taisuke Uehara, Akira Yokoi, Ken Aoshima, Satoshi Tanaka, Tadashi Kadowaki

Anal Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative profiling of polar cationic metabolites in human cerebrospinal fluid by reversed-phase nanoliquid chromatography/mass spectrometry.
Khin Than Myint, Ken Aoshima, Satoshi Tanaka, Tatsuji Nakamura, Yoshiya Oda

Anal Chem· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis